Quality agents, LLC:1661462 [26-002367] high level support for development of a feasibility study and business plan for a viral vector manufacturing facility
Active Purchase Order Awarded Last action
- Contract number
- 75N98026P00123
- Awardee
-
Quality Agents, LLC UEI K5C4E47JDVW1
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Obligated
- $200,000
Award facts
- Opportunity
-
- specialized consultants to provide a feasibility review and develop a business plan for development of a viral vector manufacturing facility in a current cell manufacturing facility Pre-Solicitation · 26002367 · Posted Mar 4, 2026
- Contract value 100% obligated
- $200,000.00 Current and potential, with all options
- Completion date 52% complete
- Current and potential, with all options
- Funding agency
- NIH Clinical Center National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
Quality Agents, LLC has been awarded a $200,000 firm fixed-price purchase order by the NIH Clinical Center to provide high-level support for the development of a feasibility study and business plan for a viral vector manufacturing facility. The contract was awarded on March 13, 2026, with an ultimate completion date of May 12, 2027, and will be performed in Bethesda, Maryland. This procurement originated from a pre-solicitation notice posted on March 4, 2026, which sought specialized consultants to evaluate the establishment of a viral vector manufacturing capability within an existing cell manufacturing facility at the NIH Clinical Center. The facility is intended to produce retroviral and lentiviral vectors, adeno-associated viruses (AAV), and prepare for future nanoparticle manufacturing to support Phase I and early Phase II clinical studies.
The procurement was conducted under Federal Acquisition Regulation Part 13 Simplified Acquisition Procedures, which permits single-source contracting when deemed appropriate. No set-aside designation was applied to this opportunity, meaning it was open to all eligible contractors. The contract falls under NAICS Code 541990 (All Other Professional, Scientific, and Technical Services) and supports the NIH Clinical Center's mission to advance translational research by establishing advanced manufacturing capabilities for gene therapy vectors and related biopharmaceutical products used in clinical investigation.
Quick answers
Who was awarded contract 75N98026P00123?
75N98026P00123 was awarded to Quality Agents, LLC by Office of Logisitics and Acquisition Operations (National Institutes of Health) on March 13, 2026.
How much is contract 75N98026P00123 worth?
The government has obligated $200,000 on 75N98026P00123.
Which agency awarded contract 75N98026P00123?
Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026P00123, with funding from NIH Clinical Center (National Institutes of Health).
Was contract 75N98026P00123 competed?
The extent of competition for 75N98026P00123 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award